Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + cipepofol + remifentanil anesthesia for painless gastrointestinal endoscopy without tracheal intubation
ChiCTR2600124189Phase 4Not yet recruiting
- Sponsor
- Huai'an First People's Hospital
- Start
- May 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine, ciprofol, propofol and remifentanil in gastrointestinal polyp (4 arms), sponsored by Huai'an First People's Hospital. Primary endpoints: Cognitive assessment, Respiratory depression and 2 more. Planned start May 2026; status: not yet recruiting.
02
Drugs
esketamineciprofolpropofolremifentanil
03
Conditions
gastrointestinal polyp
Beyond the preview
Go deeper on ChiCTR2600124189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124189.